TCL Archive In Brief: Capp Heads Roentgen Ray Society; Annual Lecture, Chair Honors Charles Spurr June 22, 1990
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer February 25, 2011
TCL Archive In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened September 8, 1978
TCL Archive In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials January 19, 1996
